PatientsLikeMe ™

ALS
Skip over navigation
Join Now (It's free!)

Already a member? Log in

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


See also: Gammaglobulin (IVIg)

What is Intravenous Immuno Globulin (IVIG)? Intravenous Immune Globulin (IVIG) is a human blood product consisting of antibodies which is used to treat immune disorders including myaesthenia gravis (MG) and multifocial motor neuropathy (MMN). It is sometimes trialed on ALS patients during the diagnostic process to rule out other illnesses. Read more...Click to read more below


Reasons Taken

27 patients in the community are taking or have taken Intravenous Immuno Globulin (IVIG).

Reason # Patients Percentage of patients
Other 15 55%
Slow my ALS progress 10 37%
Fatigue 1 3%
Don't know 1 3%

Dosages

Based on the patients currently taking Intravenous Immuno Globulin (IVIG).

  25 mg month 30 mg month 35 g month 55 mg month 100 g month 800 mg month 1100 mg month 10000 mg day
  1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Intravenous Immuno Globulin (IVIG) or how long patients were taking Intravenous Immuno Globulin (IVIG) before stopping.

Currently taking Intravenous Immuno Globulin (IVIG)

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
0
3
0
5

Stopped taking Intravenous Immuno Globulin (IVIG)

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
4
6
3
1
1
0
Why Patients Stopped Taking Intravenous Immuno Globulin (IVIG) (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 10 67% Did not seem to work: 67%
Course of treatment ended 6 40% Course of treatment ended: 40%
Doctor's advice 4 27% Doctor's advice: 27%
Side effects too severe 3 20% Side effects too severe: 20%
Expense 1 7% Expense: 7%
Other 1 7% Other: 7%

Patient Reported Evaluations

Results from 3 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 50% 1
Moderate 50% 1

Other

Side-effects (as an overall problem)

Severe 0% 0
Moderate 0% 0
Mild 33% 1
None 67% 2

Top reported side-effects include: Headache

Summary results are based on 3 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 3)

  • reugie
    Mouth/throat: mild
    Arms: mild
    Chest: mild
    Legs: mild
    See profile
  • reugie
  • by reugie
    Nov 02, 2008
  • EfficacyCan't tell
  • Side-effectsNone
  • Slow my ALS progress

  • EfficacyMajor
  • Side-effectsMild
  • Other

See all evaluation results for Intravenous Immuno Globulin (IVIG)



Back to top